INVITE (7/20 at 2pm ET): Guggenheim Grand Rounds: Head And Neck Cancer Treatment Paradigm Changes; Multiple Pivotal Readouts Over The Next 12 Months

Research evidence excerpt

INVITE (7/20 at 2pm ET): Guggenheim Grand Rounds: Head And Neck Cancer Treatment Paradigm Changes; Multiple Pivotal Readouts Over The Next 12 Months

pective Representatives make any representation

or warranty regarding, accuracy or completeness of any information contained therein

or otherwise. Neither Guggenheim nor any other Presenter nor any of their respective

Representatives shall be liable to any person in any way whatsoever for any losses,

costs or claims for reliance on the materials. Guggenheim and/or any other Presenter

may have a business relationship with certain attendees and/or issuers mentioned during

the event or in any materials provided, or may otherwise underwrite, hold a position,

buy or sell as principal in the securities of any issuer mentioned. Guggenheim may have

in the past provided, may currently be providing and may in the future seek to provide

investment banking, financial advisory and other services to, and have other material

relationships with, attendees and/or issuers of securities, loans and other financial

instruments discussed during the event or referred to in any materials. With respect to

any position Guggenheim or any Presenter may hold, Guggenheim or such Presenter

may have interests different from or adverse to your interests. None of the materials

provided may be reproduced or redistributed, in whole or in part, to any other person or

published in whole or in part for any purpose absent the written consent of Guggenheim.

By registering for and/or attending the event and/or accepting delivery of the materials,

you will be deemed to acknowledge and agree to the matters set forth above. Copyright

2026 by Guggenheim Securities, LLC, a FINRA registered broker-dealer. All rights

reserved. Invitation is non-transferable.